| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Research and development | -$10.2M+5.4% | -$10.8M+6.3% | -$11.5M-37.5% | -$8.4M-16.9% | -$7.2M-217.1% | -$2.3M |
| General and administrative | -$8.5M+11.1% | -$9.6M+11.4% | -$10.8M-13.1% | -$9.5M-39.7% | -$6.8M-446.5% | -$1.2M |
| Total operating expenses | -$18.7M+8.1% | -$20.4M+8.8% | -$22.3M-24.5% | -$17.9M-28.1% | -$14.0M-298.8% | -$3.5M |
| Loss from operations | -$18.7M+8.1% | -$20.4M+8.5% | -$22.3M-25.2% | -$17.8M-28.6% | -$13.8M-297.4% | -$3.5M |
| Interest income, net | $244K-31.6% | $357K-27.7% | $494K+31.7% | $375K+2904.1% | $12K+243.6% | $4K |
| Foreign exchange (loss) gain, net | -$834K-799.9% | $119K+127.7% | -$429K-346.9% | -$96K-31.8% | -$73K+24.4% | -$96K |
| Loss before income tax | -$19.3M+2.9% | -$19.9M+10.4% | -$22.2M-26.8% | -$17.5M-26.0% | -$13.9M-288.7% | -$3.6M |
| Income tax | -$861K-60.4% | -$537K-577.2% | -$79K+14.7% | -$93K-2219.8% | -$4K+25.6% | -$5K |
| Net loss | -$20.2M+1.2% | -$20.4M+8.3% | -$22.3M-26.6% | -$17.6M-26.6% | -$13.9M-288.3% | -$3.6M |
| Net loss per share attributable to common stockholders - basic | -$0.61+31.5% | -$0.89+48.0% | -$1.71-15.5% | -$1.48-8.0% | -$1.37-3.0% | -$1.33 |
| Net loss per share attributable to common stockholders - diluted | -$0.61+31.5% | -$0.89+48.0% | -$1.71-15.5% | -$1.48-8.0% | -$1.37-3.0% | -$1.33 |
| Weighted average common stock - basic | $33.0M+44.1% | $22.9M+75.9% | $13.0M+9.5% | $11.9M+16.9% | $10.2M+279.1% | $2.7M |
| Weighted average common stock - diluted | $33.0M+44.1% | $22.9M+75.9% | $13.0M+9.5% | $11.9M+16.9% | $10.2M+279.1% | $2.7M |
Source: SEC EDGAR XBRL. % change vs prior period shown where available.
Source: SEC EDGAR 10-K and 10-Q filings. Up to 10 years annual / 16 quarters shown.